|
|
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss |
| 1R01EY033475-01A1 |
|
NEI |
2022 |
|
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
| 3R00EY029330-05S1 |
|
NEI |
2022 |
|
|
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells |
| 4R00EY029011-03 |
|
NEI |
2022 |
|
|
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy |
| 5K08EY029766-04 |
|
NEI |
2022 |
|
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
| 5R00EY029330-05 |
|
NEI |
2022 |
|
|
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis |
| 1R21DA055427-01 |
|
NIDA |
2022 |
|
|
Psychostimulants, Attention Deficit and Basal Ganglia Disorders |
| 1R21DA055980-01 |
|
NIDA |
2022 |
|
|
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools |
| 1R21DA056293-01 |
|
NIDA |
2022 |
|
|
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo |
| 5R01DA045596-05 |
|
NIDA |
2022 |
|
|
Learning to see again: biological constraints on cortical plasticity and the implications for sight restoration technologies |
| 1 R01 EY031312-01A1 |
FINE, IONE |
NEI |
2021 |